Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Biochemical Pharmacology|June 25, 2008
Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophagesMin Hee Kim, Hwa Young Lee, Eunmiri Roh, et al.The Journal of Investigative Dermatology|December 21, 2012
cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorderEunmiri Roh, Cheong-Yong Yun, Ji Young Yun, et al.Cancer Research|November 13, 2020
GSK3β-Mediated Expression of CUG-Translated WT1 Is Critical for Tumor ProgressionHisae Yoshitomi, Kun Y Lee, Ke Yao, et al.Journal of Medicinal Food|May 26, 2026
Hydrolyzed Keratin Peptide Enhances Hair Condition and Promotes Hair RegenerationSan Kim, Jun Young Kim, Ji Won Leem, et al.Carcinogenesis|October 14, 2017
Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODCDong Joon Kim, Mee-Hyun Lee, KangDong Liu, et al.Archives of Pharmacal Research|March 13, 2009
Synthesis and nuclear factor-kappaB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamidesJae-Hwan Kwak, Sun-Woo Won, Tae-Jeong Kim, et al.Molecular Cancer Therapeutics|June 29, 2017
ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPKGe Gao, Tianshun Zhang, Qiushi Wang, et al.Oncogene|June 16, 2018
Targeting PRPK and TOPK for skin cancer prevention and therapyEunmiri Roh, Mee-Hyun Lee, Tatyana A Zykova, et al.British Journal of Pharmacology|March 14, 2015
cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamideHyoeun Shin, Seung Deok Hong, Eunmiri Roh, et al.Molecular Cancer Therapeutics|February 28, 2018
Targeting PRPK Function Blocks Colon Cancer MetastasisTatyana Zykova, Feng Zhu, Lei Wang, et al.Pageof 6